These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Metabolic and hemodynamic effects of nicardipine during pacing-induced angina pectoris. Thomassen A, Bagger JP, Nielsen TT, Henningsen P. Am J Cardiol; 1987 Feb 01; 59(4):219-24. PubMed ID: 3812268 [Abstract] [Full Text] [Related]
23. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina. Aronow WS, March H, Vangrow JS, Cassidy J, Kern JC, Khemka M, Vawter M, Pagano J. Br Heart J; 1974 Nov 01; 36(11):1078-81. PubMed ID: 4155953 [No Abstract] [Full Text] [Related]
24. Physiologic approach to the treatment of angina pectoris. Mason DT, Spann JF, Zelis R, Amsterdam EA. N Engl J Med; 1969 Nov 27; 281(22):1225-8. PubMed ID: 4981526 [No Abstract] [Full Text] [Related]
25. Haemodynamic effects of different beta blockers in angina pectoris. Aström H, Jonsson B. Scott Med J; 1977 Jan 27; 22(1):64-8. PubMed ID: 13496 [Abstract] [Full Text] [Related]
26. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris. Detry JM, Melin J, Brasseur LA, Cosyns J, Rousseau MF. Am J Cardiol; 1981 Jan 27; 47(1):109-15. PubMed ID: 6893896 [Abstract] [Full Text] [Related]
40. Protective effect of prenylamine against vulnerability to ventricular fibrillation in the normal and ischemic canine myocardium. Schoeneberger AS, Verrier RL, Lown B. Proc Soc Exp Biol Med; 1979 May 27; 161(1):56-9. PubMed ID: 441070 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]